[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"femoracetabular-impingement\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:femoracetabular-impingement":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100595856","phase-4-efficacy-of-ketorolac-for-postoperative-pain-management-in-hip-arthroscopy-100595856",false,"NCT07037888","Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy","Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective, Randomized, Clinical Trial","Inclusion Criteria:\n\n* Patients undergoing hip arthroscopy over the age of 18 with Dr. T. Sean Lynch\n* Diagnosis of femoroacetabular impingement (FAI)\n\nExclusion Criteria:\n\n* Patients with inability to consent and\u002For do not speak English\n* Patients with conditions contraindicated with NSAIDs (medication allergy, peptic ulcer disease, bleeding diathesis, and renal disease)\n* Patients with history of drug and alcohol use disorder\n* Patients with chronic analgesia (filled two opioid prescriptions within 6 months of the surgery)\n* Patients with psychotropic medication usage\n* Patients who take pentoxifylline, probonecid, aspirin, and\u002For NSAIDs who cannot stop taking it for the study\n* Patients who are not discharged same day after surgery","ALL","18 Years","89 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","The goal of this clinical trial is to learn whether the medication ketorolac can help manage pain after hip arthroscopy as well or better than the standard opioid-based pain medications. This study focuses on adult patients (over 18 years old) undergoing hip arthroscopy at Henry Ford Health System in Detroit, Michigan. Both men and women are included, and all participants must be able to consent and communicate in English.\n\nThe main questions it aims to answer are:\n\nCan ketorolac help control pain as effectively or better than opioids after hip arthroscopy?\n\nWill ketorolac use reduce the amount of opioid medication needed after surgery?\n\nResearchers will compare the group receiving ketorolac to the group receiving standard opioid pain medications to see if ketorolac reduces pain and opioid use after surgery.\n\nParticipants will:\n\nBe randomly assigned to one of two groups:\n\nThe control group, which receives the current standard pain management protocol (hydrocodone-acetaminophen and diazepam)\n\nThe experimental group, which receives the same protocol plus ketorolac and a stomach-protecting medication (omeprazole)\n\nReceive their assigned pain medications after hip arthroscopy\n\nBe asked to:\n\nTake the prescribed medications after discharge\n\nComplete a pain journal for 5 days following surgery, documenting pain levels and any side effects\n\nComplete follow-up surveys and assessments at 2 weeks, 6 weeks, and 3 months after surgery\n\nThe main measurement researchers will use is the Visual Analog Scale (VAS) for pain on post-operative day 4. Additional measures include how many narcotic pills are used and results from PROMIS physical function and pain interference scores.\n\nThe hope is that ketorolac will provide equal or better pain control without the risks of addiction and side effects associated with opioid medications. If successful, this approach could offer a safer alternative for managing pain after hip arthroscopy. Participants may personally benefit by having effective pain relief with fewer risks, and future patients could benefit from improved pain management options.",[27,28],"Femoracetabular Impingement","Hip Arthroscopy",[30,28,31,32,33,34],"Sports Medicine","FAI","Opioids","Ketorolac","Multi-modal pain","RECRUITING","2026-06-26",{"date":38,"type":39},"2026-06-30","ACTUAL",{"date":41,"type":39},"2023-12-13",{"date":43,"type":21},"2026-12",{"name":45,"class":46},"Henry Ford Health System","OTHER",1,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":61,"conditions":62,"keywords":63,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":47},"100634177","clinical-decision-making-in-fais-100634177","NCT07536295","Clinical Decision-Making in FAIS","Optimizing Treatment Pathway and Clinical Desicion-making in Young Adults With Femoroacetabular Impingement Syndrome","CDM-FAIS","Inclusion Criteria:\n\n1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures\n2. Male or Female, Age 18-35 years inclusive.\n3. First consultation at participating site with clinical diagnosis of FAIS by a hip orthopaedic surgeon, including positive impingement tests and reduced hip ROM in the transverse plane compatible with FAIS.\n4. Radiographic cam and\u002For pincer morphology on standard imaging (e.g. α-angle \\>60°, lateral center-edge angle \\>40°, crossover sign) as per local protocol.\n5. Willingness and ability to participate rehabilitation and complete the recommended physiotherapy sessions and attend scheduled follow-up visits.\n6. Ability to perform basic squat \u002F hip-hinge tasks safely in the motion lab, as judged by the treating clinician.\n\nExclusion Criteria:\n\n1. Previous surgery on the bilareral hip.\n2. History of major hip trauma or pediatric hip disease (e.g. Slipped capital femoral epiphysis, Perthes disease).\n3. Developmental dysplasia (lateral center-edge ≤20°) or other severe structural deformity incompatible with the standard FAIS pathway.\n4. Radiographic signs of hip degeneration (Tönnis grade \\>2).\n5. Other musculoskeletal conditions that significantly interfere with assessments (e.g. symptomatic lumbar disc disease, severe knee pathology, recent adductor muscle pathology).\n6. Contraindications to MRI (e.g. non-MRI compatible pacemaker or implant, severe claustrophobia not manageable with standard care).\n7. Contraindications to X-ray or MRI related to pregnancy: known pregnancy at any time, or positive pregnancy test prior to imaging; breastfeeding women will not undergo additional research imaging.\n8. Inability to perform basic squat\u002Fhip-hinge tasks safely (e.g. due to balance, pain or cardiopulmonary limitations).","35 Years",{"count":58,"type":21},60,[60],"NA","Femoroacetabular impingement syndrome is increasingly recognized as a contributor to cartilage injury and early hip osteoarthritis. Both structured conservative care and arthroscopic surgery can improve pain and function, but a major unresolved clinical problem is deciding who should continue conservative care and who should escalate to surgery, and when. Evidence indicates that shorter symptom duration before surgery is associated with better long-term improvement, meaning delays may reduce the chance of achieving meaningful recovery. Current decision-making still depends largely on static imaging and passive clinical examination, which do not capture the dynamic, movement-related nature of the condition, while advanced three-dimensional imaging and laboratory motion analysis are not practical for routine clinical monitoring. This study aims to address this gap by developing and validating feasible, clinic-ready dynamic assessment methods and integrating weight-bearing pelvic and spinal alignment with three-dimensional hip modeling to support more objective, individualized, and timely treatment decisions.",[27],[64],"FAIS","NOT_YET_RECRUITING","2026-05-05",{"date":68,"type":39},"2026-05-06",{"date":70,"type":21},"2026-07",{"date":72,"type":21},"2029-07",{"name":74,"class":46},"Universitaire Ziekenhuizen KU Leuven"]